SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-047991
Filing Date
2020-10-27
Accepted
2020-10-27 16:20:00
Documents
72
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rare-10q_20200930.htm   iXBRL 10-Q 3281925
2 EX-10.5 rare-ex105_443.htm EX-10.5 88907
3 EX-31.1 rare-ex311_10.htm EX-31.1 17454
4 EX-31.2 rare-ex312_8.htm EX-31.2 17432
5 EX-32.1 rare-ex321_9.htm EX-32.1 10863
6 GRAPHIC gqduqx1offjd000001.jpg GRAPHIC 40735
7 GRAPHIC g22m0czn2xbf000001.jpg GRAPHIC 53792
  Complete submission text file 0001564590-20-047991.txt   10085601

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA rare-20200930.xsd EX-101.SCH 64691
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20200930_cal.xml EX-101.CAL 51310
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20200930_def.xml EX-101.DEF 175887
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20200930_lab.xml EX-101.LAB 397825
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20200930_pre.xml EX-101.PRE 314057
13 EXTRACTED XBRL INSTANCE DOCUMENT rare-10q_20200930_htm.xml XML 1910023
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 201264340
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences